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Abstract
A finest quantitative responsive with reproducible best method was developed using designed array (Taguchi) and 
Quadratic design methodology (RSM) chromomeric spectrophotometric estimation of bulk as well as pharmaceutical 
(Tizanidine HCl). Initially (Taguchi), orthogonal array design was applied to find significant variables as well as optimum 
(better) levels. By response surface (central composite; quadratic) methodology were used to ascertain optimum to 
optimized “Better to Best” and studied values of variables (independent significant; X1=PDAB=chromogenic reagent; 
FeCl3=X2=ferric ion at optimum levels with drug constant=X3) responses (dependent Y1=absorbance) models at 
positive and negative (+1/-1 optimum spaces) levels. More-more, designed independent factorial levels “better to 
best” surface models (3D) and its polynomial (2nd order) equation was predicted the finest level which further 
can be considered as best chromomeric estimation method. The models analysis of experimental variables and 
their level showed and followed good Beer’s (5-50 µg/ml) correlation at optimized significant independent best 
(finest) level variables and in-addition validated using pharmaceutical guidelines (ICH; international conference on 
harmonization) for human use. 
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Introduction
An carbocyclic hydrochloride derivative of Tizanidine 
(muscle relaxant; 5-Chloro-N-4,5-dihydro-1H-imidazol-2-yl-2,1,3-
benzothiadiazol-4-amine i.e.) which inhibited spinal reflex transmission 
via supra-spinal effects as a agonist (α2-adrenergic). Also, having 
analgesic (pain relief) effects but non-steroidal anti-inflammatory drugs 
have also as one another effect i.e. gastro-protective. During literature, 
alicyclic amines (pyrrole/indole) condensed with p-dimethyl-amino-
benzaldehyde (PDAB in strongly acidic medium and oxidized by 
ferric ions to give colored species/products including Schiff bases) 
derivatives as chromogenic agent alone via factorial designs were used 
for estimation/determination [1-3]. Although, there is no method was 
used non-factorial (quadratic design) with chromogenic or without. 
So, our research objective was developed plus validated a sensitive 
method using array Taguchi and quadratic (factorial independent; 
central composite) response surface design via chromomeric attempt 
for best estimation spectrophotometer methodology [4-7]. All 
experimental (orthogonal array) results of array (orthogonal) trials 
responses were interpreted to find significant variables and optimum 
levels (chromomeric reagents and ferric ion additional with different 
temperature, pH, and time for reaction stability. More-over, an 
independent (quadratic) factorial design of significant variables with 
optimum (positive and negative space level) was performed and further 
studied their interactive effects. To designed better to Best level (non-
dependent); three-dimensional surface (3D plots) models constructed 
to preeminent (and also validated) fitted level of variables which can be 
considered as “Best level” for quantitative (Tizanidine HCl) estimation.
Materials and Methods
The procured chemicals and reagents were (Lobachemicals Ltd. 
and S. D. Finechem Ltd, Mumbai) p-dimethyl-aminobenzaldehyde 
chromogenic (PDAB), Ferric ions (Ferric Chloride) and acid (HCl). 
For study, independent variables (X1, X2, and X3) analytical (A/GR 
200 Precision, Anakek Services, Mumbai) weight has been taken and 
made required concentrated solutions using distilled water of abode 
production. The standard of active pharmaceutical ingredients (drug; 
Tizanidine HCl) derivative, Tizan and Sirdalud (2.288 mg; both) 
was obtained from M/S Jackson Pharmaceuticals Pvt. Ltd., Amritsar 
(Punjab) and market drug formulation from Sun Pharma and Novartis 
(Mumbai) respectively as gift sample. The hydrogen ion concentration 
(pH meter; Aminco, Swastika, Ambala) and UV-Visible Double- Beam 
[spectral bandwidth (1.8 nm) with wavelength accuracy (2 nm) and 
optical path of quartz cells length (10 mm) (SL 160, Elico, Hyderabad) 
spectrophotometer at fixed wavelength was used through-out for 
analytical analysis as quantitative as absorbance measurement.
Solutions
The obtained gift sample (Tizanidine HCl; 10 mg) was taken 
and dissolved in distilled water to acquired (100 µg/ml) desired 
concentration., chromomeric (PDAB; 1% w/v) solution was prepared 
and diluted by using hydrochloric (50% v/v) and aqueous ferric ion (1% 
v/v; ferric chloride) solution and further used analytical determination 
as quantitative.
Methodology 
A statistical (Mini-Tab, version 17.0) quadratic response 
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surface [7,8] non-factorial methodology was used for design 
independent variables and spaces (levels). The diverse generated trials 
(experimentally T-1 to 20; Table 1) levels were additional diluted with 
distilled water for made the volumetric (25 ml) finally. After that finally 
obtained volumes (25 ml) of significant variables (A and B) solutions 
were heated at different temperatures (40-80oC), pH (1 to 6) and time 
(5 to 60 min) and measured the absorbance against blank (λmax 425 nm; 
Figure 1). Before performed experimentally, again generated (BB1 to 
13; Table 2) runs but using significant level of variables at positive and 
negative optimum space (+1 to -1; better to best) level and analyzed 
their responses (experimental vs predicted; Table 2) model fitness to 
find out the variables level as best.
Model and analysis 
The orthogonal array was used to find out optimum (better) level 
of significant variables which further used as independent (quadratic 
design i.e. response surface methodology explored and developed) 
level for an improved program). By data (Absorbance=R1) analyzed at 
optimum (better) to find optimized (best) levels were simultaneously. 
Also, illustrated designed surface (3D) models and independently 
factorial generated equation were included all statistically coefficients 
of each level responses (Table 2) for “better to best” model fitness as 
best-fitted. 
Calibration curve
The solutions (2 ml; Tizanidine hydrochloride) were pipette out 
and added chromogenic [PDAB (4 ml) followed by ferric ion solution 
(6 ml) as significant; 10 ml)] agent and further diluted to made 
optimized (best; 5-50 µg/ml) concentration with distilled water. The 
resulted of significant variables solutions were sonicated (15 min) 
subsequently heated at optimum temperature (60-65oC) at time (20 
minutes) and measured the absorbance (at 425 nm; pH 2) against the 
blank. The calibration curve was constructed by plotted the graph between 
absorbance and concentration (absorbance vs µg/ml) and showed better 
linearity with well coefficient of correlation (Figures 2 and 3).
Method of Estimation 
For the quantitative analysis, model drug derivative (tizanidine 
hydrochloride) in bulk and tablets [2.288 mg drug; Tizan (Sun-Pharma) 
and Sirdalud (Novartis)] were procured from the market, weighed (20 
tablets of each brand) and powdered. The drug powdered was accurately 
weighed (10 mg equivalent for both the brands), transferred to flasks 
(volumetric; I and II) added distilled water (25 ml) then sonicated (15 
min.) and finally distilled water was added to make-up the volume 
(up-to 100 ml) of both flask contained solution. The volumetric flask 
Design Trials Levels (ml) Absorbance
PDAB reagent Ferric Chloride At λmax 425 nm
T-1 1 1 0.233
T-2 2 2 0.252
T-3 3 3 0.276
T-4 1 4 0.291
T-5 2 1 0.312
T-6 3 2 0.326
T-7 4 3 0.335
T-8 5 4 0.348
T-9 6 5 0.352*
T-10 4 6 0.355*
T-11 5 7 0.356*
T-12 6 8 0.349*
T-13 7 5 0.347
T-14 8 6 0.341
T-15 9 7 0.338
T-16 7 8 0.331
T-17 8 9 0.324
T-18 9 10 0.320
T-19 10 9 0.317
T-20 10 10 0.315
Aristech (*) value indicated the significant variable (better) optimum level response 
Table 1: Generated Array Trials At Diverse Levels (1 To 10).
 































































Figure 1: Plots for optimization a) Temperature; b) pH; c) pH d) reaction time 
for complex stability vs absorbance.
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(I and II) solutions were filtered (Whatman filter paper no. 40). The 
sample solutions were prepared from [flask (I and II)] stock solution 
by appropriate dilutions and significant variable with optimized level 
to get desired concentrations with-in the Beer’s law range limits and 
measured the absorbance against blank at 425 nm (λmax).
Recovery and validation 
At this study carried-out, using (API 1, 2 and 3 mg of drug and 
tablet) powder containing the equivalent to (10 mg drug) weight. After 
that, the methodology found amount was calculated the recovery (%) 
and intra/inter-day precision (%) relative standard deviation [9,10] 
analysis to be satisfactory or not.
Result and Discussion
The chromogenic agent (PDAB) was selected (followed by dissolved 
in acid in the presence of ferric chloride) due to reagent [3] promising 
for the successful estimation of drugs having fused heterocyclic ring 
(Tizanidine HCl structure having indole heterocyclic moiety) in acid 



















































Scheme 1: Better to Best (Level) Method.
Code=variables 
(Unit)
 “better to best” Independent (Space=Coded) Levels
X1=PDAB(ml) 4.00 (-1=1) 5.00 (0=2) 6.00 (+1=3)
X2= FeCl3 (ml) 5.00 (-1=1) 6.00 (0=2) 7.00 (+1=3)
Dependant Constraints
Y1 = Absorbance 0.56≤Y 1≥0.71
Design Results
Runs-Code Variables
Independent Dependent (Y1) Response (R1)
X1 X2 Observed Predicted
BB-1 1.00 1.00 0.665 0.670
BB-2 2.00 1.00 0.571 0.570
BB-3 3.00 1.00 0.601 0.600
BB-4 1.00 2.00 0.640 0.640
BB-5 1.00 3.00 0.592 0.590
BB-6 2.00 3.00 0.581 0.580
BB-7 3.00 2.00 0.658 0.660
BB-8 2.00 2.00 0.586 0.590
BB-9 2.00 2.00 0.590 0.590
BB-10 2.00 1.00 0.564 0.570
BB-11 2.00 2.00 0.590 0.590
BB-12 2.00 2.00 0.589 0.590
BB-13 3.00 3.00 0.705 0.700
Surface Design (3D) Best Model
Terms Model X1 X2 X1X2 X12 X22 Lack of Fit
F value 383.4 63.4 33.40 691.65 1061.8 37.20 1.70
Intercept 0.59 0.011 0.0076 0.0445 0.064 -0.012
p. value (Prob>F) 0.0001 0.0007 . < 0.0001 < 0.0001 0.0005 0.3040
R-Square Adjusted R2 Predicted R2 Std. Dev %CV
0.996 0.994 0.982 0.0035 0.67
F-value Less than 0.0500 indicate model terms are significant and Lack of fit value 
Greater than 0.1000 indicate the model terms are not significant
Table 2: Result Of Quadratic Design Methodology.
Brand Amount (mg) Percentage ± SD
Labeled Found Relative Labeled 
Tizan
2.288
2.282 0.0763 99.74 ± 0.0761 
Sirdalud 2.281 0.0989 99.73 ± 0.0986 


















Figure 2: Linear correlation plots between actual and predicted values.
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negative space (level of X1 along with positive level space) had a more 
pronounced effect than any other optimum (better) levels. During 
model analysis, optimized “better to best” levels of variables (X1 and X2) 
were negative (-1=X1=4 ml and 5 ml) and positive (+1=X2=6 or 7 ml) 
ferric ions space as comparison Also, an improved (good correlation 
coefficient) effects showed by response (R1=absorbance at optimized 
level), therefore this model design space can be used to investigate its 
surface (3D plots) which showed the independent effect of optimized 
levels of significant variables as on response (Y1). Further-more, 
this model design of optimized of significant variables (X1 and X2) 
levels independent effect can be used for “better to best” quantitative 
estimation method.
The significant variables best fitted levels (X1=PDAB=4 ml followed 
by ion solution X2=FeCl3=6 ml) solutions into a volumetric flasks 
having drug solution (Tizanidine HCl=2 ml) were taken and finally 
made the volume with distilled water (25 ml). Further, the solutions 
were heated at optimal temperature (60-65oC for time 20 min at pH 2) 
for complete reaction and absorbance was measured against the blank 
at 425 nm wavelength (Table 3).
Discussion and Conclusion
The best designed method has better absorptivity (4.717×103 liter/
mole/cm) along with superior’s sensitivity (Sand-ell’ per absorbance-
units is 0.0615 µg/cm2/0.001) and regression equation [y=0.0198×–
0.0673] showed better linearity with correlation coefficient (best fitted 
R-square value is 0.9964) as compared with existing method. During 
the intra (0.627) as well as inter-day (0.504) analysis has been found 
relative deviation (0.207) and quantitation (0.627) with-in limits and 
this higher recovery percentage indicated that there was no excipients 
interference. Further-more, indicated and concluded that the Taguchi 
array via Quadratic “independent” factorial designed chromomeric 
level (of better to best method) can be further considered as best for 
quantitative and quality reliable method of estimation. 
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Figure 3: 3Dsurface models showed the levels (better to best) effect on 
response (Y1).
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